Detalles de la búsqueda
1.
The emerging predictive and prognostic role of HER2 in HER2-negative early breast cancer: a retrospective study.
Breast Cancer Res Treat
; 2024 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38743174
2.
Thromboxane biosynthesis in cancer patients and its inhibition by aspirin: a sub-study of the Add-Aspirin trial.
Br J Cancer
; 129(4): 706-720, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37420000
3.
Neratinib in advanced HER2-positive breast cancer: experience from the royal Marsden hospital.
Breast Cancer Res Treat
; 195(3): 333-340, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35976513
4.
Clinical outcomes in patients with triple negative or HER2 positive lobular breast cancer: a single institution experience.
Breast Cancer Res Treat
; 192(3): 563-571, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35119530
5.
A review on the added value of whole-body MRI in metastatic lobular breast cancer.
Eur Radiol
; 32(9): 6514-6525, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35384456
6.
Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study.
Lancet Oncol
; 22(2): 212-222, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33460574
7.
Impact of timing of adjuvant chemothapy for early breast cancer: the Royal Marsden Hospital experience.
Br J Cancer
; 125(2): 299-304, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34017085
8.
Bridging The Age Gap: observational cohort study of effects of chemotherapy and trastuzumab on recurrence, survival and quality of life in older women with early breast cancer.
Br J Cancer
; 125(2): 209-219, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33972747
9.
Clinical validity of clinical treatment score 5 (CTS5) for estimating risk of late recurrence in unselected, non-trial patients with early oestrogen receptor-positive breast cancer.
Breast Cancer Res Treat
; 186(1): 115-123, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33222093
10.
Incidence of cardiotoxicity and validation of the Heart Failure Association-International Cardio-Oncology Society risk stratification tool in patients treated with trastuzumab for HER2-positive early breast cancer.
Breast Cancer Res Treat
; 188(1): 149-163, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33818652
11.
Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population.
Breast Cancer Res Treat
; 189(3): 689-699, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34414532
12.
Statins as Potential Chemoprevention or Therapeutic Agents in Cancer: a Model for Evaluating Repurposed Drugs.
Curr Oncol Rep
; 23(3): 29, 2021 02 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33582975
13.
Germline BRCA1 and BRCA2 testing for breast cancer survivors.
J Med Genet
; 57(8): 528-530, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31511339
14.
Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial.
Lancet Oncol
; 21(10): 1296-1308, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32919527
15.
Pathological complete response to neoadjuvant systemic therapy in 789 early and locally advanced breast cancer patients: The Royal Marsden experience.
Breast Cancer Res Treat
; 179(1): 101-111, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31535318
16.
Long-term outcome with targeted therapy in advanced/metastatic HER2-positive breast cancer: The Royal Marsden experience.
Breast Cancer Res Treat
; 178(2): 401-408, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31432365
17.
Palbociclib and endocrine therapy in heavily pretreated hormone receptor-positive HER2-negative advanced breast cancer: the UK Compassionate Access Programme experience.
Breast Cancer Res Treat
; 174(3): 731-740, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30656459
18.
Development and responses of brain metastases during treatment with trastuzumab emtansine (T-DM1) for HER2 positive advanced breast cancer: A single institution experience.
Breast J
; 24(3): 253-259, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28833867
19.
The prevalence of unmet needs in 625 women living beyond a diagnosis of early breast cancer.
Br J Cancer
; 117(8): 1113-1120, 2017 Oct 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28859057
20.
Correction to: Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population.
Breast Cancer Res Treat
; 191(1): 223-224, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34625861